Europe

EMA investigates Allergan blockbuster hopeful Esmya on reports of liver damage
Fierce Pharma
Mon, 12/4/17 - 09:32 pm
EMA
Allergan
Esmya
Europe
uterine fibroids
Europe’s medtech alliance seeks prompt action on new med device rules
Mass Device
Wed, 11/22/17 - 10:02 am
Europe
devices
FDA, EMA and PMDA Plot Harmonized Path for Antibiotics
RAPS.org
Sat, 11/18/17 - 09:46 am
FDA
EMA
PMDA
antibioitics
Europe
Japan
Boehringer wins EU approval for Humira biosimilar
BioPharma Dive
Wed, 11/15/17 - 08:53 pm
Boehringer Ingelheim
Europe
Humira
biosimilars
Cyltezo
AbbVie
Nearly Half of Recent EU Approvals Based on a Single Pivotal Study
RAPS.org
Sat, 11/11/17 - 11:07 am
drug approvals
EU
Europe
Here's Why Merck & Co., Inc. Tanked 14% in October
Motley Fool
Wed, 11/8/17 - 06:20 pm
Merck
Keytruda
Europe
non-small cell lung cancer
Brexit with no deal risks chaos in UK drug supply, report warns
Reuters
Wed, 11/8/17 - 10:24 am
Brexit
Europe
UK
Novartis seeks European approval for cell therapy Kymriah
Reuters
Mon, 11/6/17 - 09:25 am
Novartis
Europe
CAR-T
Kymriah
diffuse large B-cell lymphoma
acute lymphoblastic leukemia
FDA to recognize GMP inspections by 8 EU drug regulators
BioPharma Dive
Fri, 11/3/17 - 09:32 am
FDA
GMP inspections
Europe
Bristol-Myers, J&J sink cash into a new $95M European biotech fund
Endpoints
Mon, 10/30/17 - 11:24 pm
JNJ
Bristol-Myers Squibb
Europe
biotech
BioGeneration Ventures
Why What’s Bad for Merck Is Good For Bristol-Myers
Barron's
Mon, 10/30/17 - 11:07 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Europe
Merck Keytruda sales soar, but European application pulled
Yahoo/Reuters
Sat, 10/28/17 - 10:44 am
Merck
Keytruda
Europe
Johnson & Johnson investing $350M in EU biologics operation, adding 200 jobs
Fierce Pharma
Mon, 10/9/17 - 11:18 am
JNJ
Europe
biologics
Ireland
drug manufacturing
Aftermath of Brexit Could Cripple EMA
Xtalks
Thu, 09/28/17 - 06:23 pm
Europe
EMA
Brexit
Merck KGaA, Pfizer's cancer drug Bavencio gets EU nod
Yahoo/Reuters
Thu, 09/21/17 - 08:38 am
Bavencio
Europe
Merck KGaA
Pfizer
Merkel cell carcinoma
Samsung Bioepis first to secure EMA backing for Herceptin biosimilar
BioPharma Dive
Mon, 09/18/17 - 09:23 am
Samsung Bioepis
EMA
Europe
biosimilars
Herceptin
Roche
breast cancer
GSK’s triple-med COPD inhaler wins recommendation for approval in EU
Drug Delivery Business News
Fri, 09/15/17 - 09:13 am
GSK
COPD
Trelegy Ellipta
Europe
Biogen, Samsung Humira copy wins EU approval
Fierce Pharma
Fri, 08/25/17 - 09:52 am
Biogen
Samsung Bioepis
Europe
Humira
AbbVie
Imraldi
biosimilars
EMA and FDA will now share trade secrets, allowing both regulators to act on each other’s inspection reports
Endpoints
Thu, 08/24/17 - 11:38 am
FDA
EMA
Europe
trade secrets
Drug blocked by European regulators improves quality of life for MS patients
Drug Delivery Business News
Fri, 08/18/17 - 12:09 pm
Europe
MS
multiple sclerosis
cladribine

Pages